ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645317; 2) Community: the network communities that were significantly associated with the response to NSC 645317; 3) Molecule: the relationships between components within communities and NSC 645317; 4) MDR: the compounds that were significantly associated with the NSC 645317.

NSC Compound Enrichment Correlation
NSC 722779 dabequine 0.0228506033927957 0.19219076
NSC 724615 thiopyrimidine-CH3 0.0228506033927957 0.12624337
NSC 726444 4,11-bis[[2-(methylamino)ethyl]amino]-3-[(dimethylamino)meth yl]-1H-naphtho[2,3-f]indole-5,10-dione 0.0228506033927957 0.39079783
NSC 726718 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid 0.0228506033927957 0.43284373
NSC 726902 Null 0.0228506033927957 0.32405705
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0228506033927957 0.48701949
NSC 728512 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine 0.0228506033927957 0.36461539
NSC 730294 Null 0.0228506033927957 0.26078897
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0228506033927957 0.34445341
NSC 737697 Null 0.0228506033927957 0.33109743
Total:127  Current:80    [First] [Prev] [Next] [Last]